An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia

• Main Authors: Purwati, Andang Miatmoko, Nasronudin, Eryk Hendrianto, Deya Karsari, Aristika Dinaryanti, Nora Ertanti, Igo Syaiful Ihsan, Disca Sandyakala Purnama, Tri Pudy Asmarawati, Erika Marfiani, Yulistiani, Alfian Nur Rosyid, Prastuti Asta Wulaningrum, Herley Windo Setiawan, Imam Siswanto, Ni Nyoman Tri Puspaningsih
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Public Library of Science 2021
• Subjects: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• Online Access: https://repository.unair.ac.id/123702/2/C-15%20Artikel.pdf; https://repository.unair.ac.id/123702/1/C-15%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/123702/3/C-15%20Similarity.pdf; https://repository.unair.ac.id/123702/; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252302; https://doi.org/10.1371/journal.pone.0252302
• Institution: Universitas Airlangga

A potent therapy for the infectious coronavirus disease COVID-19 is urgently required with, at the time of writing, research in this area still ongoing. This study aims to evaluate the in vitro anti-viral activities of combinations of certain commercially available drugs that have recently formed pa...